SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 25, 17:00
620.65
-1.3 (-0.21%)
VOLUME 113,143
LIVE
NSE
Nov 25, 17:00
621.15
-1 (-0.16%)
VOLUME 1,253,979
News on Ranbaxy Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Top 10 stocks to keep an eye on November 25 

8.44 am | 25 Nov 2014 |  Source: CNBC-TV18

CNBC-TV18's Research Team recommends Top 10 stocks to watch in today's trade - Crompton Greaves, Jindal Saw, Amtek Auto, Ahmednagar Forgings, Amara Ra...

CCI begins public scrutiny of Holcim-Lafarge deal

2.25 pm | 22 Nov 2014 |  Source: PTI

The comments with respect to the Holcim-Lafarge deal need to be submitted to the CCI (Competition Commission of India) within 15 days, along with supp...

Be careful while betting on midcaps; like Kotak: Dimensions 

10.00 am | 21 Nov 2014 |  Source: CNBC-TV18

Ajay Srivastava is bullish on cement, tyre, IT and pharma space. Among stocks, Srivastava likes JK Lakshmi, Shree cement, Sun Pharma, Lupin, Tech Mahi...

Here's why Sun, Lupin, DRL are still best pharma bets 

1.04 pm | 20 Nov 2014 |  Source: CNBC-TV18

Once the closure of the merger (Sun-Ranbaxy) is done and market begins to take due notice of the benefits that can come through on the acquisition the...

Here are few trading ideas from Mithil Pradhan 

12.48 pm | 20 Nov 2014 |  Source: CNBC-TV18

Watch the interview of Mithil Pradhan of Violet Arc Global Managers with Sonia Shenoy and Anuj Singhal on CNBC-TV18, in which he shared his readings a...

Here are top 10 stocks to keep an eye on November 20 

8.47 am | 20 Nov 2014 |  Source: CNBC-TV18

Here are top 10 stocks to keep an eye on November 20 - Axis Bank, Wockhardt, DLF, Ranbaxy, Alok Industries, Kotak Mahindra Bank, ING Vysya, Hindalco, ...

Stocks in news: Ranbaxy, Texmaco Rail, ILandFS Engg

7.54 am | 19 Nov 2014 |  Source: Moneycontrol.com

Ranbaxy | Texmaco Rail | M&M | Infosys | ILandFS Engineering and Power Grid are stocks, which are in news today....

Ranbaxy sues USFDA; US Court to hear motion 

7.39 pm | 18 Nov 2014 |  Source: CNBC-TV18

USFDA had revoked tentative approvals granted to Ranbaxy for generic versions of two drugs - AstraZeneca's heartburn drug Nexium & Roche's antiviral d...

Ranbaxy to exit Nifty Junior index from November 28

7.34 pm | 18 Nov 2014 |  Source: PTI

These changes would be effective from November 28, 2014. Ranbaxy has been already dropped from NSE's benchmark index, Nifty....

Ranbaxy sues FDA for revoking approvals for Nexium, Valcyte

2.55 pm | 18 Nov 2014 |  Source: Reuters

In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency'...

Angel Broking neutral on Ranbaxy Laboratories

12.25 pm | 18 Nov 2014 |  Source: Moneycontrol.com

Angel Broking has maintained a neutral rating on Ranbaxy Laboratories, in its November 3, 2014 research report....

Merger with Ranbaxy might get delayed: Sun CFO Baldota 

11.59 am | 14 Nov 2014 |  Source: CNBC-TV18

The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally....

Super Six intraday picks for the day 

8.15 am | 13 Nov 2014 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com suggests buying Ranbaxy Laboratories with a target of Rs 702-712 and UPL with a target of Rs 371-380....

Is Sun Pharma expensive at current valuations? 

4.20 pm | 11 Nov 2014 |  Source: CNBC-TV18

Purely from a short-term point of view there might not be too much of significant run up but purely on a fundamental basis Sun Pharma looks fairly str...

Sun Pharma a must in core portfolio: Experts 

3.38 pm | 11 Nov 2014 |  Source: CNBC-TV18

Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through....

Buy IRB Infra, Ranbaxy, Adani Ports: Vishal B Malkan 

12.27 pm | 11 Nov 2014 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com is of the view that one can buy Adani Ports for a target price of Rs 315 and Indiabulls Real Estate for a target pr...

Bull's Eye: Buy Bharat Forge, Ashok Leyland, Ranbaxy Labs 

8.54 am | 11 Nov 2014 |  Source: CNBC-TV18

Vishal B Malkan, malkansview.com advises buying IRB Infrastructure for a target price of Rs 285 and Ranbaxy Labs for a target price of Rs 720....

Buy IRB Infra, OBC, Ranbaxy Laboratories: Vishal Malkan 

1.24 pm | 10 Nov 2014 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com recommends buying Ranbaxy Laboratories for a target price of Rs 735 and Oriental Bank of Commerce for a target pric...

Taro Q2 results boost Sun Pharma, stock hits record high

11.10 am | 10 Nov 2014 |  Source: Moneycontrol.com

Taro's gross profit, as a percentage of net sales, was at 79 percent compared to 77.7 percent. During the quarter, operating income increased USD 40.0...

Bull's Eye: Buy Bharat Forge, Titan, OBC, Ranbaxy Labs 

8.59 am | 10 Nov 2014 |  Source: CNBC-TV18

Manav Chopra, Nirmal Bang advises buying Bharat Forge for a target price of Rs 870 and Adani Power for a target price of Rs 54....

1 2 3 4 5 6
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.